table network network 2
demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 severe or critically
infections other than COVID-19
Ad26.ZIKV.001 (Ad26-Vectored Anti-Zika Virus Vaccine) Salisch

0 studies excluded by filtering options 1

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons